Skip to content

Probiotics in Folliculitis

Investigating the effect of oral probiotic drug in treatment of patients with Staphyloccocal folliculitis and Staphylococcus aureus carriers compared to placebo a double-blind randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240730062590N1
Enrollment
50
Registered
2024-09-01
Start date
2024-09-22
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Staphylococcous Aureus Folliculitis. Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere

Interventions

Intervention 1: Control group: daily receiving two capsules of Probiotics LACTOCARE (from Zist Takhmir company, Tehran , Iran ) after eating meal. Intervention 2: Intervention group: daily receiving t

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 99 Years

Inclusion criteria

Inclusion criteria: Staphylococcal Folliculitis confirmed by Panculture Staphylococcus aureus carrier confirmed by Panculture Age more than 16 years old

Exclusion criteria

Exclusion criteria: Pregnancy Lactation Diarrhea Consumption of drugs or foods' containing probiotics during 1 month before entering to study Consumption of antibiotics during 1 month before entering to study

Design outcomes

Primary

MeasureTime frame
Staphylococcal colonization. Timepoint: Before study - 3 months after starting study - 3 months after study termination. Method of measurement: Performing panculture.

Secondary

MeasureTime frame
Clinical outcome. Timepoint: Before sudy - 3 months after starting study - 3 months after study termination. Method of measurement: Counting patients' papules and pustules.;Quality of life. Timepoint: Before study - 3 months after starting study - 3 months after study termination. Method of measurement: Dermatology Life Quality Questionaire.;Treatment complications. Timepoint: Before study - 3 months after starting study - 3 months after study termination. Method of measurement: Question from patient or observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Cheshmeh ghasabani

Shiraz University of Medical Sciences

hoseinghasabani@gmail.com+98 71 3633 3099

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026